Infectious Complications in Head and Neck Cancer Patients Treated with Cetuximab: Propensity Score and Instrumental Variable Analysis

BACKGROUND: To compare the infection rates between cetuximab-treated patients with head and neck cancers (HNC) and untreated patients. METHODOLOGY: A national cohort of 1083 HNC patients identified in 2010 from the Taiwan National Health Insurance Research Database was established. After patients we...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ching-Chih, Ho, Hsu-Chueh, Hsiao, Shih-Hsuan, Huang, Tza-Ta, Lin, Hon-Yi, Li, Szu-Chin, Chou, Pesus, Su, Yu-Chieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509146/
https://www.ncbi.nlm.nih.gov/pubmed/23209663
http://dx.doi.org/10.1371/journal.pone.0050163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509146/
https://www.ncbi.nlm.nih.gov/pubmed/23209663
http://dx.doi.org/10.1371/journal.pone.0050163

Ejemplares similares